Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2013, Article ID 978202, 10 pages
http://dx.doi.org/10.1155/2013/978202
Research Article

Highlights on Novel Technologies for the Detection of Antibodies to Ro60, Ro52, and SS-B

1Immunology and Allergology Laboratory Unit, Azienda Sanitaria di Firenze, San Giovanni di Dio Hospital, Florence, Italy
2Department of Research, INOVA Diagnostics Inc., 9900 Old Grove Road, San Diego, CA 92131-1638, USA
3Rheumatology Unit, Department of Internal Medicine, San Giovanni di Dio Hospital, Azienda Sanitaria di Firenze, Florence, Italy
4Rheumatology Unit, L. Sacco University Hospital, Milan, Italy

Received 23 July 2013; Accepted 26 September 2013

Academic Editor: Marvin J. Fritzler

Copyright © 2013 M. Infantino et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Mahler and M. J. Fritzler, “Epitope specificity and significance in systemic autoimmune diseases,” Annals of the New York Academy of Sciences, vol. 1183, pp. 267–287, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Mahler, “Sm peptides in differentiation of autoimmune diseases,” Advances in Clinical Chemistry, vol. 54, pp. 109–128, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Mahler, E. D. Silverman, J. Schulte-Pelkum, and M. J. Fritzler, “Anti-Scl-70 (topo-I) antibodies in SLE: myth or reality?” Autoimmunity Reviews, vol. 9, no. 11, pp. 756–760, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Schulte-Pelkum, M. Fritzler, and M. Mahler, “Latest update on the Ro/SS-A autoantibody system,” Autoimmunity Reviews, vol. 8, no. 7, pp. 632–637, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Ghillani, C. André, C. Toly et al., “Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: results of a multicentric study,” Autoimmunity Reviews, vol. 10, no. 9, pp. 509–513, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. M. R. Arbuckle, M. T. McClain, M. V. Rubertone et al., “Development of autoantibodies before the clinical onset of systemic lupus erythematosus,” The New England Journal of Medicine, vol. 349, no. 16, pp. 1526–1533, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. K. H. Ching, P. D. Burbelo, C. Tipton et al., “Two major autoantibody clusters in systemic lupus erythematosus,” PLoS ONE, vol. 7, no. 2, Article ID e32001, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. F. J. López-Longo, M. Rodríguez-Mahou, M. Escalona-Monge, C. M. González, I. Monteagudo, and L. Carreño-Pérez, “Simultaneous identification of various antinuclear antibodies using an automated multiparameter line immunoassay system,” Lupus, vol. 12, no. 8, pp. 623–629, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. M. J. Fritzler, “Advances and applications of multiplexed diagnostic technologies in autoimmune diseases,” Lupus, vol. 15, no. 7, pp. 422–427, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. O. Shovman, B. Gilburd, O. Barzilai et al., “Evaluation of the BioPlex 2200 ANA screen. Analysis of 510 healthy subjects: Incidence of natural/predictive autoantibodies,” Annals of the New York Academy of Sciences, vol. 1050, pp. 380–388, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. O. Shovman, B. Gilburd, G. Zandman-Goddard, A. Yehiely, P. Langevitz, and Y. Shoenfeld, “Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases,” Autoimmunity, vol. 38, no. 1, pp. 105–109, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. J. G. Hanly, L. Su, V. Farewell, and M. J. Fritzler, “Comparison between multiplex assays for autoantibody detection in systemic lupus erythematosus,” Journal of Immunological Methods, vol. 358, no. 1-2, pp. 75–80, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. W. H. Robinson, C. DiGennaro, W. Hueber et al., “Autoantigen microarrays for multiplex characterization of autoantibody responses,” Nature Medicine, vol. 8, no. 3, pp. 295–301, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Mahler, A. Radice, W. Yang et al., “Development and performance evaluation of novel chemiluminescence assays for detection of anti-PR3 and anti-MPO antibodies,” Clinica Chimica Acta, vol. 413, no. 7-8, pp. 719–726, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Bentow, A. Swart, J. Wu et al., “Clinical performance evaluation of a novel rapid response chemiluminescent immunoassay for the detection of autoantibodies to extractable nuclear antigens,” Clinica Chimica Acta, vol. 424, pp. 141–147, 2013. View at Publisher · View at Google Scholar
  16. K. Op De Beéck, P. Vermeersch, P. Verschueren et al., “Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis,” Autoimmunity Reviews, vol. 12, no. 2, pp. 137–143, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Mahler, M. J. Fritzler, and M. Blüthner, “Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies,” Arthritis Research & Therapy, vol. 7, no. 1, pp. R19–R29, 2005. View at Google Scholar · View at Scopus
  18. M. B. Eisen, P. T. Spellman, P. O. Brown, and D. Botstein, “Cluster analysis and display of genome-wide expression patterns,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 25, pp. 14863–14868, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. E. K. L. Chan, M. J. Fritzler, A. Wiik et al., “AutoAbSC.Org—autoantibody standardization committee in 2006,” Autoimmunity Reviews, vol. 6, no. 8, pp. 577–580, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. S. A. Lee, J. Kahng, Y. Kim et al., “Comparative study of immunofluorescent antinuclear antibody test and line immunoassay detecting 15 specific autoantibodies in patients with systemic rheumatic disease,” Journal of Clinical Laboratory Analysis, vol. 26, no. 4, pp. 307–314, 2012. View at Google Scholar
  21. H. Hansson-Hamlin and J. Rönnelid, “Detection of antinuclear antibodies by the Inno-Lia ANA update test in canine systemic rheumatic disease,” Veterinary Clinical Pathology, vol. 39, no. 2, pp. 215–220, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. S. S. Copple, T. B. Martins, C. Masterson, E. Joly, and H. R. Hill, “Comparison of three multiplex immunoassays for detection of antibodies to extractable nuclear antibodies using clinically defined sera,” Annals of the New York Academy of Sciences, vol. 1109, pp. 464–472, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Avaniss-Aghajani, S. Berzon, and A. Sarkissian, “Clinical value of multiplexed bead-based immunoassays for detection of autoantibodies to nuclear antigens,” Clinical and Vaccine Immunology, vol. 14, no. 5, pp. 505–509, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. M. J. Fritzler, F. Behmanesh, and M. L. Fritzler, “Analysis of human sera that are polyreactive in an addressable laser bead immunoassay,” Clinical Immunology, vol. 120, no. 3, pp. 349–356, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. P. M. Bayer, S. Bauerfeind, J. Bienvenu et al., “Multicenter evaluation study on a new HEp2 ANA screening enzyme immune assay,” Journal of Autoimmunity, vol. 13, no. 1, pp. 89–93, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. X. Bossuyt, “Evaluation of two automated enzyme immunoassays for detection of antinuclear antibodies,” Clinical Chemistry and Laboratory Medicine, vol. 38, no. 10, pp. 1033–1037, 2000. View at Google Scholar · View at Scopus
  27. H.-P. Lehmann, I. Fuhling, C. Ott, B. Hudepohl, and M. Haass, “HEp2 ANA EIA: a new fully automated assay for the screening of antinuclear antibodies,” Israel Medical Association Journal, vol. 2, no. 8, pp. 646–648, 2000. View at Google Scholar · View at Scopus
  28. J. Schmitt and W. Papisch, “Recombinant autoantigens,” Autoimmunity Reviews, vol. 1, no. 1-2, pp. 79–88, 2002. View at Publisher · View at Google Scholar · View at Scopus